These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6107790)
21. [Current problems in multiple sclerosis (immunogenetic aspect) (review of the literature)]. Khondkarian OA; Zavalishin IA Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):292-300. PubMed ID: 76384 [No Abstract] [Full Text] [Related]
22. Letter: Transfer factor in multiple sclerosis. Behan PO Lancet; 1976 Jul; 2(7979):258. PubMed ID: 59273 [No Abstract] [Full Text] [Related]
23. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes. Offner H; Raun NE; Konat G; Fog T; Clausen J Acta Neurol Scand; 1977 Dec; 56(6):465-74. PubMed ID: 605771 [TBL] [Abstract][Full Text] [Related]
24. [Recent notions concerning the treatments used in multiple sclerosis (author's transl)]. Gonsette RE J Belge Med Phys Rehabil; 1978; 1(3):213-6. PubMed ID: 231031 [No Abstract] [Full Text] [Related]
25. Transfer factor in treatment of multiple sclerosis. Basten A; McLeod JG; Pollard JD; Walsh JC; Stewart GJ; Garrick R; Frith JA; Van Der Brink CM Lancet; 1980 Nov; 2(8201):931-4. PubMed ID: 6107585 [TBL] [Abstract][Full Text] [Related]
27. Multiple sclerosis: an overview. Rose AS Adv Neurol; 1981; 31():3-9. PubMed ID: 7325046 [No Abstract] [Full Text] [Related]
28. A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients. Lamoureux G; Cosgrove J; Duquette P; Lapierre Y; Jolicoeur R; Vanderland F Clin Exp Immunol; 1981 Mar; 43(3):557-64. PubMed ID: 7026094 [TBL] [Abstract][Full Text] [Related]
29. [Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis]. Créange A; Farge-Bancel D Rev Neurol (Paris); 2008 Mar; 164(3):207-15. PubMed ID: 18405770 [TBL] [Abstract][Full Text] [Related]
30. Amyotrophic lateral sclerosis: failure of transfer factor therapy. Jonas S; Wichter M; Spitler L Ann Neurol; 1979 Jul; 6(1):84. PubMed ID: 507764 [No Abstract] [Full Text] [Related]
31. The evidence justifying immunosuppression therapy in multiple sclerosis. Mertin J Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967 [No Abstract] [Full Text] [Related]
32. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis]. Cendrowski W Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575 [No Abstract] [Full Text] [Related]
35. [Thymus-dependent therapeutic immunosuppression in multiple sclerosis and myasthenia]. Lobzin VS; Golovkin VI Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):176-81. PubMed ID: 7072415 [TBL] [Abstract][Full Text] [Related]
36. Intense immunosuppression and autologous hematopoietic stem cell transplantation for multiple sclerosis. Fassas A Haematologica; 2003 Mar; 88(3):244-5. PubMed ID: 12651258 [No Abstract] [Full Text] [Related]
37. The HLA system and multiple sclerosis. Jersild C Birth Defects Orig Artic Ser; 1978; 14(5):123-70. PubMed ID: 99191 [No Abstract] [Full Text] [Related]
38. [Therapy with transfer factor in diseases with disorders of the cellular immune reaction]. Schröder I Z Gesamte Inn Med; 1980 Jan; 35(2):86-91. PubMed ID: 6996355 [TBL] [Abstract][Full Text] [Related]
39. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis. Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062 [No Abstract] [Full Text] [Related]
40. Studies of HLA antigens in multiple sclerosis. Jersild C Boll Ist Sieroter Milan; 1978 Jan; 56(6):516-30. PubMed ID: 415750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]